Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 31/74 ]
NYSE | Common Stock
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
It operates through Biotechnology, Life Sciences, and Diagnostics segments.
The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions.
Its Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands.
The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians' offices, reference laboratories, and other critical care settings.
The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984.
Danaher Corporation was founded in 1969 and is headquartered in Washington, the District Of Columbia.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Apr 22, 25 | 1.88 Decreased by -2.08% | 1.64 Increased by +14.38% |
| Jan 29, 25 | 2.14 Increased by +2.39% | 2.16 Decreased by -0.93% |
| Oct 22, 24 | 1.71 Decreased by -15.35% | 1.57 Increased by +8.92% |
| Jul 23, 24 | 1.72 Decreased by -16.10% | 1.57 Increased by +9.55% |
| Apr 23, 24 | 1.92 Decreased by -18.64% | 1.71 Increased by +12.28% |
| Jan 30, 24 | 2.09 Decreased by -27.18% | 1.91 Increased by +9.42% |
| Oct 24, 23 | 2.02 Decreased by -21.09% | 1.87 Increased by +8.02% |
| Jul 25, 23 | 2.05 Decreased by -25.72% | 2.01 Increased by +1.99% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 6.54 B Increased by +142.78% | 1.09 B Increased by +0.65% | Increased by +16.61% Decreased by -58.54% |
| Sep 30, 24 | 5.80 B Decreased by -15.64% | 818.00 M Decreased by -27.55% | Increased by +14.11% Decreased by -14.11% |
| Jun 30, 24 | 5.74 B Decreased by -19.76% | 907.00 M Decreased by -17.99% | Increased by +15.79% Increased by +2.20% |
| Mar 31, 24 | 5.80 B Decreased by -19.13% | 1.09 B Decreased by -24.97% | Increased by +18.77% Decreased by -7.22% |
| Dec 31, 23 | 2.69 B Decreased by -67.82% | 1.08 B Decreased by -51.66% | Increased by +40.07% Increased by +50.23% |
| Sep 30, 23 | 6.87 B Decreased by -10.31% | 1.13 B Decreased by -27.21% | Increased by +16.43% Decreased by -18.84% |
| Jun 30, 23 | 7.16 B Decreased by -7.66% | 1.11 B Decreased by -33.29% | Increased by +15.45% Decreased by -27.76% |
| Mar 31, 23 | 7.17 B Decreased by -6.78% | 1.45 B Decreased by -13.90% | Increased by +20.23% Decreased by -7.64% |